The titration schedule (increasing the dose every 4 weeks) is designed to be a long-term protocol
APRIL 2026 LAUNCH Foundayo is a New Drug - What That Means Foundayo is a New Drug - What That Means Foundayo (orforglipron) is a non-peptide, small-molecule GLP-1 that received FDA approval on April 1, 2026 [2] - making it one of the newest GLP-1 medications available
Key Ingredients: 6 Peptides that boost skin elasticity, reduce post hyperpigmentation, control pores, renew skin, calm and alleviate skin, and improve the look of fine lines and wrinkles
By improving the transportation of fatty acids into cells, L-carnitine facilitates their conversion into energy, making it a useful tool in weight loss and body composition strategies
It affects more than 1 in 3 adults under age 65 and half of the people over 65 in the U.S